Skip to main content
    B

    Biovie Inc (BIVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.44
    -0.07 (-4.42%)

    Market Cap: $12.12M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Biovie Inc (BIVI) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Biovie (BIVI) to earn -$0.63 per share in the fiscal year ending Jun 30, 2027. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$0.57.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Jun 30, 2027
    -$0.63
    EPS consensus
    Fiscal year ending Jun 30, 2028
    -$0.57
    EPS consensus
    Next report
    Feb 4, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Jun 30, 2027-$0.63-$0.63 to -$0.631
    Jun 30, 2028-$0.57-$0.57 to -$0.571

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202700
    Fiscal year ending Jun 30, 202800

    Frequently Asked Questions About BIVI

    What is the BIVI stock forecast?

    Consensus analyst estimates put Biovie's EPS at -$0.63 for the fiscal year ending Jun 30, 2027.

    What EPS do analysts expect from BIVI next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.63, with estimates from -$0.63 to -$0.63 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.57, with estimates from -$0.57 to -$0.57 from 1 analyst.

    How many analysts cover BIVI?

    1 analyst estimates EPS for Biovie for the fiscal year ending Jun 30, 2027.